Metformin treatment for adolescent obesity has limited long-term benefits
Glaser Pediatric Research Network Obesity Study Group. Metformin extended release treatment of adolescent obesity: A 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Arch Pediatr Adolesc Med 2010;164:116-23.
PII: S0022-3476(10)00406-3
doi:10.1016/j.jpeds.2010.05.010
© 2010 Mosby, Inc. All rights reserved.
